Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
US-2020113916-A1 · Apr 16, 2020 · US
11 beta-short chain substituted estradiol analogs and their use in the treatment of menopausal symptoms and estrogen sensitive cancer
US9315539B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9315539-B2 |
| Application number | US-67628703-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 1, 2003 |
| Priority date | Oct 1, 2002 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to novel 11-β estradiol ester compounds and their use as locally active estrogens in the treatment of the symptomology of menopause and to treat estrogen sensitive cancers, including breast cancer.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating the symptomology of menopause in a patient while reducing the risk that the patient develops an estrogen-sensitive cancer, the method comprising administering to said patient an effective amount of a selective estrogen receptor modulator (SERM) which has the chemical structure: Where R is a sidechain group of at least 5 non-hydr…
Assignees
Inventors
Classifications
- C07J1/00Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9315539B2 cover?
- The present invention relates to novel 11-β estradiol ester compounds and their use as locally active estrogens in the treatment of the symptomology of menopause and to treat estrogen sensitive cancers, including breast cancer.
- Who is the assignee on this patent?
- Hochberg Richard, Univ Yale
- What technology area does this patent fall under?
- Primary CPC classification C07J1/00. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).